Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 28,045
Sort by:

Female infertility - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Female infertility - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, his...

January 2022 60 pages

Female Infertility - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Female Infertility- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth underst...

January 2022 200 pages

Female Trichomoniasis Vaginalis - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Female Trichomoniasis Vaginalis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

FGFRpositive Gastroesophageal Cancer - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'FGFRpositive Gastroesophageal Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding o...

January 2022 60 pages

Fibrocystic Breast Condition - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fibrocystic Breast Condition - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...

January 2022 60 pages

Fibrocystic Breast Condition - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Fibrocystic Breast Condition- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-dep...

January 2022 200 pages

Fibrodysplasia Ossificans Progressiva (FOP) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fibrodysplasia Ossificans Progressiva (FOP) - Epidemiology Forecast to 2032' report delivers an in-depth understa...

January 2022 60 pages

Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2022

US$ 2,000.00

This report can be delivered to the clients within 48 hours DelveInsight’s, “Fms-like tyrosine kinase 3 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companie...

January 2022 70 pages

Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Focal Segmental Glomerulosclerosis (FSGS) - Epidemiology Forecast to 2032' report delivers an in-depth understand...

January 2022 60 pages

Follicular Lymphoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Follicular Lymphoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth unders...

January 2022 200 pages

Follitropin alfa– Biosimilar Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “Follitropin alfa– Biosimilar 2022,” report provides comprehensive insights about 10+ companies and 10+ marketed and pipel...

January 2022 60 pages

Food Allergy – Epidemiology Forecast—2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Food Allergy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Food Hypersensitivity - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Food Hypersensitivity - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Fragile X Syndrome (FXS) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fragile X Syndrome (FXS) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...

January 2022 60 pages

France Healthcare Outlook Report, 2022

US$ 1,995.00

This report can be delivered to the clients within 24 Hours DelveInsight’s, “France Healthcare Outlook 2022,” report provides comprehensive insights about healthcare scenario, regulatory policies an...

January 2022 60 pages

Friedreich's Ataxia - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Friedreich's Ataxia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...

January 2022 60 pages

Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Frontotemporal Dementia (FTD) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

FTase (Farnesyltransferase) inhibitor– Pipeline Insight, 2022

US$ 1,500.00

This report can be delivered to the clients within 48 hrs DelveInsight’s, “FTase (Farnesyltransferase) inhibitor - Pipeline Insight, 2022” report provides comprehensive insights about 2+ companies a...

January 2022 60 pages

Fuchs Dystrophy - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fuchs Dystrophy - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...

January 2022 60 pages

Fuchs Dystrophy - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Fuchs Dystrophy- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understand...

January 2022 200 pages

Fuchs Endothelial Corneal Dystrophy (FECD) – Epidemiology Forecast—2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast to 2032' report delivers an in-depth understan...

January 2022 60 pages

Fuchs Endothelial Corneal Dystrophy (FECD) - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Fuchs Endothelial Corneal Dystrophy (FECD)- Market Insights, Epidemiology, and Market Forecast-2032' report deli...

January 2022 200 pages

Functional Constipation - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Functional Constipation- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth un...

January 2022 200 pages

Functional Dyspepsia - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Functional Dyspepsia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...

January 2022 60 pages

Fungal Pneumonia - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Fungal Pneumonia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Fungal Pneumonia - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Fungal Pneumonia- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understan...

January 2022 200 pages

G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'G Protein-Coupled Receptor (GPCR) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of t...

January 2022 60 pages

GABA Receptor Antagonist - Pipeline Insight, 2022

US$ 1,250.00

This report can be delivered to the clients within 48 hrs “GABA Receptor Antagonist - Pipeline Insight, 2022” report by DelveInsight offers comprehensive insights of the pipeline (under development)...

January 2022 60 pages

Galactosemia - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Galactosemia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historica...

January 2022 60 pages

Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastric Neuroendocrine Tumors - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

Gastric Neuroendocrine Tumors - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastric Neuroendocrine Tumors- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-de...

January 2022 200 pages

Gastro Intestinal Bleeding - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastro Intestinal Bleeding - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...

January 2022 60 pages

Gastro Intestinal Bleeding - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastro Intestinal Bleeding- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth...

January 2022 200 pages

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) - Epidemiology Forecast to 2032' report delivers an in-de...

January 2022 60 pages

Gastroesophageal Adenocarcinoma - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gastroesophageal Adenocarcinoma- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-...

January 2022 200 pages

Gastroesophgeal adenocarcinoma -Epidemiology Forecast -2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastroesophgeal adenocarcinoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Gastrointestinal Cancer - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gastrointestinal Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...

January 2022 60 pages

Gaucher disease Type 1 - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gaucher disease Type 1 - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...

January 2022 60 pages

Gender dysphoria - Epidemiology Insight - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gender dysphoria - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histo...

January 2022 60 pages

Gene and Cell Therapies in Rare Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene and Cell Therapies in Rare Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understandi...

January 2022 60 pages

Gene And Cell Therapies In Rare Disorder - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene And Cell Therapies In Rare Disorder- Market Insights, Epidemiology, and Market Forecast-2032' report delive...

January 2022 200 pages

Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene and Cell Therapies targeting CNS disorders - Epidemiology Forecast to 2032' report delivers an in-depth unde...

January 2022 60 pages

Gene and Cell Therapies Targeting CNS Disorders - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene and Cell Therapies Targeting CNS Disorders- Market Insights, Epidemiology, and Market Forecast-2032' report...

January 2022 200 pages

Gene Therapies for Cardiomyopathies - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene Therapies for Cardiomyopathies - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Gene Therapies for Cardiomyopathies - Market Insight, Epidemiology and Market Forecast -2032

US$ 7,500.00

This report can be delivered to the clients within 7-10 Business Days DelveInsight's 'Gene Therapies for Cardiomyopathies- Market Insights, Epidemiology, and Market Forecast-2032' report delivers an...

January 2022 200 pages

Gene Therapy for Ocular Rare Disease - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene Therapy for Ocular Rare Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding o...

January 2022 60 pages

Gene therapy in rare diseases - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Gene therapy in rare diseases - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the d...

January 2022 60 pages

General Anxiety Disorder (GAD) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'General Anxiety Disorder (GAD) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the...

January 2022 60 pages

Generalized Anxiety Disorder - Epidemiology Forecast - 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Generalized Anxiety Disorder - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the di...

January 2022 60 pages

Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast to 2032

US$ 3,950.00

This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Generalized Myasthenia Gravis (gMG) - Epidemiology Forecast to 2032' report delivers an in-depth understanding of...

January 2022 60 pages

Filters

Search

Categories

131
14,546
11,885
333
72
1,078

Publishers

72
1
1,760
342
469
292
33
4
1,872
635
92
3,109
8
109
111
554
55
5
5
6
23
18
23
205
30
34
6,128
13
12
142
363
8
25
84
385
8
14
49
179
7
2,002
139
579
2,786
7
24
44
31
54
61
7
2,538
40
34
11
22
16
38
2
4
83
4
26
50
1
139
11
118
36
20
61
32
50
33
27
32
42
326
877
49
88
80
59
37
2
14
22
2

Regions

8
7
7
7
7
7
7
6
6
5
3
2
2
1
1
1
247
59
50
48
47
46
42
27
22
22
19
18
17
16
15
15
15
14
14
14
14
14
14
13
13
13
13
13
13
13
13
13
13
13
13
12
12
12
12
11
11
11
11
11
10
10
10
10
10
9
9
9
7
6
6
5
184
13
12
8
431
235
126
56
49
33
29
8
7
6
6
6
6
6
5
5
5
4
3
3
5
5
5
4
3
1
1
1
1
1
2
2
77
25,440

Price

—

Date

—

Pages

—

Offers

44
5
1